2m 2m 2m 2m 2m 2m 2m
AMARIN SP ADR (AMRN)
NASDAQ
$14.55+$0.07 (+0.52%)
Price as of Jun 03, 2026 4:10 PM EDT- $303.8MMarket Cap
- 21.09%1-Year Change
- Drug Manufacturers - GeneralIndustry
AMARIN SP ADR (AMRN)
$14.55+$0.07 (+0.52%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 182.8M -20.06% | 228.6M -25.51% | 306.9M -16.87% | 369.2M -36.69% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 120.9M +48.52% | 81.4M -50.84% | 165.5M -31.73% | 242.5M -47.50% | |
Sales and Marketing Expense | 115.0M -24.49% | 152.3M -23.82% | 199.9M -34.32% | 304.4M -25.45% | |
Research and Development Expense | -19.8M -5.09% | -20.9M -6.08% | -22.2M -26.94% | -30.4M +3.77% | |
Depreciation and Amortization Expense | 3.0M +3.74% | 2.9M +3.92% | 2.8M +10.22% | 2.5M +12.11% | |
Total Operating Expenses | 171.0M -1.24% | 173.2M -25.72% | 233.1M -33.08% | 348.4M -22.82% | |
Operating Profit | -50.2M -45.35% | -91.8M +35.82% | -67.6M -36.16% | -105.9M -1,108.08% | |
Interest Income | 10.9M -19.03% | 13.4M +12.98% | 11.9M +320.82% | 2.8M +131.07% | |
Interest Expense | -7,000 0.00% | -7,000 -12.50% | -8,000 -46.67% | -15,000 -88.37% | |
Interest Income and Expense and Net | 10.8M -19.04% | 13.4M +13.00% | 11.9M +322.79% | 2.8M +157.01% | |
Total Nonoperating Income and Expense | 3.3M +172.77% | 1.2M -41.78% | 2.1M +378.78% | -740,000 +145.03% | |
Income before Taxes | -36.0M -53.31% | -77.2M +43.84% | -53.7M -48.30% | -103.8M -1,019.36% | |
Income Taxes | 2.8M -44.81% | 5.0M -8.43% | 5.4M +172.37% | 2.0M -43.91% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -38.8M -52.79% | -82.2M +39.03% | -59.1M -44.13% | -105.8M -1,468.91% | |
Net Income from Continuing Operations Applicable to Common | -36.0M -53.31% | -77.2M +43.84% | -53.7M -48.30% | -103.8M -1,019.36% | |
Basic EPS and Net Income | -0.09 -55.00% | -0.20 +33.33% | -0.15 -42.31% | -0.26 -1,400.00% | |
Diluted EPS and Net Income | -0.09 -55.00% | -0.20 +33.33% | -0.15 -42.31% | -0.26 -1,400.00% | |
Basic Weighted Average Shares | 415.0M +0.98% | 410.9M +0.81% | 407.7M +1.62% | 401.2M +1.30% | |
Diluted Weighted Average Shares | 415.0M +0.98% | 410.9M +0.81% | 407.7M +1.62% | 401.2M -0.33% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 134.7M +11.25% | 121.0M -39.25% | 199.3M -8.46% | 217.7M -0.81% | |
Short-Term Investments | 167.9M -3.03% | 173.2M +42.65% | 121.4M +32.40% | 91.7M -60.93% | |
Cash and Cash Equivalents and Short-Term Investments | 302.6M +2.84% | 294.2M -8.25% | 320.7M +3.65% | 309.4M -31.88% | |
Total Current Assets | 649.9M +9.15% | 595.4M -17.87% | 725.0M +5.21% | 689.1M -21.58% | |
Accumulated Depreciation | 1.5M +0.27% | 1.5M +6.60% | 1.4M -44.22% | 2.5M +28.68% | |
Property and Plant and Equipment and Net | 12,000 -25.00% | 16,000 -85.96% | 114,000 -86.96% | 874,000 -38.67% | |
Total Long-Term Assets | 1.1M -13.03% | 1.2M -10.81% | 1.4M +196.94% | 458,000 +0.44% | |
Total Assets | 670.8M -2.13% | 685.3M -17.60% | 831.7M -6.15% | 886.2M -17.03% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 194.5M +8.06% | 179.9M -30.60% | 259.3M -0.08% | 259.5M -30.00% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 11.0M -4.75% | 11.5M +26.89% | 9.1M +10.47% | 8.2M +7.28% | |
Total Liabilities | 211.5M +6.19% | 199.2M -28.76% | 279.6M -3.87% | 290.8M -27.46% | |
Retained Earnings | -1.7B +2.33% | -1.7B +5.18% | -1.6B +3.87% | -1.5B +7.44% | |
Total Stockholders Equity | 459.3M -5.53% | 486.2M -11.94% | 552.1M -7.26% | 595.3M -10.76% | |
Total Shares Outstanding | 416.2M +1.12% | 411.6M +0.68% | 408.8M +1.11% | 404.3M +1.95% | |
Cash Flow | |||||
Cash from Operating Activities | 6.7M +121.69% | -31.0M -550.87% | 6.9M +103.82% | -180.1M +170.66% | |
Capital Expenditures | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | 8.8M +119.20% | -46.0M +80.14% | -25.5M -114.56% | 175.3M +68.38% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -2.0M +40.96% | -1.4M -727.39% | 230,000 +160.69% | -379,000 -92.53% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -27.45% -31.63% | -40.15% +82.33% | -22.02% -23.20% | -28.68% -1,692.39% | |
Return on Assets | -5.72% -47.19% | -10.83% +57.44% | -6.88% -36.44% | -10.83% -1,524.92% | |
Return on Equity | -8.21% -48.16% | -15.83% +53.65% | -10.30% -38.53% | -16.76% -1,503.84% | |
Revenue Growth | -20.06% -21.37% | -25.51% +51.22% | -16.87% -54.03% | -36.69% +629.83% | |
Current Ratio | 3.34 +1.01% | 3.31 +18.33% | 2.80 +5.29% | 2.66 +12.03% | |
Cash Ratio | 0.69 +2.96% | 0.67 -12.48% | 0.77 -8.39% | 0.84 +41.71% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow